222 related articles for article (PubMed ID: 30992388)
1. NT5E is associated with unfavorable prognosis and regulates cell proliferation and motility in gastric cancer.
Hu S; Meng F; Yin X; Cao C; Zhang G
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30992388
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.
Song Y; Song C; Yang S
Cancer Biother Radiopharm; 2018 Jun; 33(5):203-211. PubMed ID: 29916747
[TBL] [Abstract][Full Text] [Related]
3. Activity of ecto-5'-nucleotidase (NT5E/CD73) is increased in papillary thyroid carcinoma and its expression is associated with metastatic lymph nodes.
Bertoni APS; Bracco PA; de Campos RP; Lutz BS; Assis-Brasil BM; Meyer ELS; Saffi J; Braganhol E; Furlanetto TW; Wink MR
Mol Cell Endocrinol; 2019 Jan; 479():54-60. PubMed ID: 30184475
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem Cell Marker Expression in Gastric Cancer Stroma.
Numakura S; Uozaki H; Kikuchi Y; Watabe S; Togashi A; Watanabe M
Anticancer Res; 2019 Jan; 39(1):387-393. PubMed ID: 30591485
[TBL] [Abstract][Full Text] [Related]
5. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
6. Targeting of NT5E by miR-30b and miR-340 attenuates proliferation, invasion and migration of gallbladder carcinoma.
Wang N; Xiang X; Chen K; Liu P; Zhu A
Biochimie; 2018 Mar; 146():56-67. PubMed ID: 29155108
[TBL] [Abstract][Full Text] [Related]
7. LINC00473 predicts poor prognosis and regulates cell migration and invasion in gastric cancer.
Zhang W; Song Y
Biomed Pharmacother; 2018 Nov; 107():1-6. PubMed ID: 30071345
[TBL] [Abstract][Full Text] [Related]
8. Ecto-5'-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line.
Dietrich F; Figueiró F; Filippi-Chiela EC; Cappellari AR; Rockenbach L; Tremblay A; de Paula PB; Roesler R; Filho AB; Sévigny J; Morrone FB; Battastini AMO
J Cancer Res Clin Oncol; 2018 Mar; 144(3):469-482. PubMed ID: 29305710
[TBL] [Abstract][Full Text] [Related]
9. Expression and clinical significance of serum NT5E protein in patients with colorectal cancer.
Wang G; Fu S; Li D; Chen Y
Cancer Biomark; 2019; 24(4):461-468. PubMed ID: 30932882
[TBL] [Abstract][Full Text] [Related]
10. MIR100HG: a credible prognostic biomarker and an oncogenic lncRNA in gastric cancer.
Li J; Xu Q; Wang W; Sun S
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30886062
[TBL] [Abstract][Full Text] [Related]
11. BCYRN1 is correlated with progression and prognosis in gastric cancer.
Zhai H; Li Y
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31652309
[TBL] [Abstract][Full Text] [Related]
12. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
[TBL] [Abstract][Full Text] [Related]
13. Dys-regulation of peripheral transcript levels of ecto-5'-nucleotidase in multiple sclerosis patients.
Kobarfard F; Noroozi R; Beirami AD; Taheri M; Ghafouri-Fard S
Hum Antibodies; 2019; 27(3):161-165. PubMed ID: 30909201
[TBL] [Abstract][Full Text] [Related]
14. NT5E CpG island methylation is a favourable breast cancer biomarker.
Lo Nigro C; Monteverde M; Lee S; Lattanzio L; Vivenza D; Comino A; Syed N; McHugh A; Wang H; Proby C; Garrone O; Merlano M; Hatzimichael E; Briasoulis E; Gojis O; Palmieri C; Jordan L; Quinlan P; Thompson A; Crook T
Br J Cancer; 2012 Jun; 107(1):75-83. PubMed ID: 22653144
[TBL] [Abstract][Full Text] [Related]
15. A Systems Oncology Approach Identifies NT5E as a Key Metabolic Regulator in Tumor Cells and Modulator of Platinum Sensitivity.
Nevedomskaya E; Perryman R; Solanki S; Syed N; Mayboroda OA; Keun HC
J Proteome Res; 2016 Jan; 15(1):280-90. PubMed ID: 26629888
[TBL] [Abstract][Full Text] [Related]
16. NT5E inhibition suppresses the growth of sunitinib-resistant cells and EMT course and AKT/GSK-3β signaling pathway in renal cell cancer.
Peng D; Hu Z; Wei X; Ke X; Shen Y; Zeng X
IUBMB Life; 2019 Jan; 71(1):113-124. PubMed ID: 30281919
[TBL] [Abstract][Full Text] [Related]
17. CD73/NT5E is a Potential Biomarker for Cancer Prognosis and Immunotherapy for Multiple Types of Cancers.
Li H; Xie P; Li P; Du Y; Zhu J; Yuan Y; Wu C; Shi Y; Huang Z; Wang X; Liu D; Liu W
Adv Biol (Weinh); 2023 Feb; 7(2):e2200263. PubMed ID: 36480312
[TBL] [Abstract][Full Text] [Related]
18. MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer.
Li C; Wu R; Xing Y
Cell Cycle; 2020 Mar; 19(5):601-609. PubMed ID: 32079456
[TBL] [Abstract][Full Text] [Related]
19. NDRG1 Controls Gastric Cancer Migration and Invasion through Regulating MMP-9.
Chang X; Xu X; Xue X; Ma J; Li Z; Deng P; Chen J; Zhang S; Zhi Y; Dai D
Pathol Oncol Res; 2016 Oct; 22(4):789-96. PubMed ID: 27154576
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-340 promotes the tumor growth of human gastric cancer by inhibiting cyclin G2.
Yin G; Zhou H; Xue Y; Yao B; Zhao W
Oncol Rep; 2016 Aug; 36(2):1111-8. PubMed ID: 27374211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
